Prostaglandins, a family of lipidic molecules released during inflammation, display immunomodulatory properties in several models. One use includes exposure of monocyte-derived dendritic cells (DCs) to a cocktail of cytokines that contains prostaglandin E 2 (PGE 2 ) for purposes of maturation; such cells are currently being used for cancer immunotherapy trials. Our analysis of the transcription profile of DCs matured in the presence of tumor necrosis factor ␣ (TNF␣) and PGE 2 revealed a strong up-regulation of indoleamine 2-3 dioxygenase (IDO), an enzyme involved in tryptophan catabolism and implicated in both maternal and T-cell tolerance. Using quantitative assays to monitor levels of IDO mRNA, protein expression, and enzyme activity, we report that PGE 2 induces mRNA expression of IDO; however, a second signal through TNF receptor (TNF- R
IntroductionProstaglandin E 2 (PGE 2 ) is a catabolite of arachidonic acid and is generated by the sequential activity of cyclo-oxygenase (COX) and prostaglandin E synthase. 1 Produced during inflammation, PGE 2 is believed to act as a counter-inflammatory agent, modulating inflammatory responses and helping to restore tissue homeostasis. For example, PGE 2 has been reported to suppress T-cell proliferation, 2,3 inhibit macrophage and dendritic-cell cytokine production (eg, and tumor necrosis factor ␣ [TNF␣] 4,5 ), and modulate antigen presentation by down-regulating expression of major histocompatability complex (MHC) II. 6 Additionally, PGE 2 may skew CD4 ϩ T cells toward a T helper cell type 2 (T H 2) phenotype 7,8 and B cells toward immunoglobulin E (IgE) production. 5 In other studies, PGE 2 has been shown to play a role in T-cell development 9 and may be an inhibitor of apoptosis in doublepositive thymocytes. 10 Consistent with these reports, expression of various prostaglandin biosynthetic enzymes and receptors has been detected in the thymus. 11 Dendritic cells (DCs) are considered to be the only antigenpresenting cell (APC) capable of priming naive T cells, and they are also potent stimulators of recall responses. 12 Briefly, DCs exist in the periphery as immature cells where they serve as "sentinels," responsible for capturing antigen. Upon maturation, DCs migrate to the draining lymphoid organs, where they may initiate immune responses. This ability to traffic out of peripheral tissue with captured antigen and enter the afferent lymph is unique to the DCs, making them the appropriate carrier of tissue-restricted antigen to lymphoid organs for the initiation of immunity. 12 Their role in priming T cells has also prompted much interest in discovering strategies to efficiently use DCs carrying tumor antigen for adoptive transfer and immunization of tumor-reactive T cells. Our understanding of DC biology, however, has not resulted in overwhelming success; few DC-based studies have reported an effect greater than the 10% rate achieved by Coley. [13][14][15] Given that DCs are capable of mediating both T-cell priming as well as T-cell inactivation (tolerance), a deeper ...